CME Outfitters to Provide Free Access to Upcoming Live DEA Webstream Update on Designer Drugs

Share Article

Expert faculty to present latest evidence and insights on the use of “club drugs” in the United States in this live DEA Museum Lecture Series event.

“...’club drugs’ have been used illegally in club settings for decades, but recent research shows that there is in an increase in use by medical doctors as treatments for conditions like depression and PTSD.”

CME Outfitters (CMEO), a leading accredited provider in continuing medical education, is pleased to announce a unique continuing education opportunity focusing on the use of designer drugs or “club drugs” across the country. On Wednesday, May 30, 2018 at 1:00 pm ET, a panel of leading experts on addiction will gather for the third of four installments of the Drug Enforcement Agency’s (DEA) Museum Lecture Series. Designer Drugs: A New Look at Some Old (and Not So Old) Drugs will be broadcast via a free live CME Outfitters webstream, offering participants CME/CE credit upon its conclusion.

Designer drugs, or “club drugs” have been used illegally in club settings for decades, but recent research shows that there is an increase in use by physicians as treatments for conditions like depression and PTSD, although they have not been approved by the FDA for such uses. The panelists will dive deeper into both the abuse of these drugs and the latest evidence for their new, legitimate clinical uses. "Although these drugs are often abused in a recreational setting, some of these so-called ‘club drugs’ can actually be used in a clinical, monitored setting to treat serious psychiatric disorders such as depression and PTSD," expressed Dr. Mark Gold.

Moderator Dr. Mark Gold, Chairman of Scientific Advisory Boards at RiverMend Health, will be joined by Dr. Gerard Sanacora, professor of Psychiatry at Yale School of Medicine, Dr. Charles Conway, professor of psychiatry at Washington University School of Medicine in St. Louis, and Dr. Jean Lud Cadet, Associated Director for Diversity and Outreach at the Intramural Research Program of NIDA, for this panel discussion.

In this webcast event, the experts will share their research on these drugs and their potential uses in a clinical setting: Dr. Sanacora will discuss his research on ketamine, a drug widely used illegally in club settings and legally as an anesthetic, and its emerging as a potential new treatment for some types of depression. “Laughing gas”, or nitrous oxide, has been used for years in dental patients and Dr. Conway’s research highlights the potential of laughing gas and other designer drugs of abuse to be used as depression treatments. Finally, Dr. Jean Lud Cadet will share the potential uses and abuse of MDMA, methamphetamine, and other drugs for the treatment of PTSD and other psychiatric diseases.

Mental health is a hot topic in America and it’s imperative that clinicians are confident in their knowledge of the available and emerging treatments for a variety of psychiatric disorders to best help their patients. This webcast, which will premiere live from 1:00pm – 2:30pm ET on Wednesday, May 30, 2018, is now open for registration. Those who wish to attend the live webstream can sign up for free at http://bit.ly/DEACME2.

For a complete list of upcoming and available activities, visit http://www.cmeoutfitters.com.

About CME Outfitters, LLC
CME Outfitters develops and distributes live, recorded and web-based, outcomes- and evidence-based educational activities to thousands of clinicians each year and offers expert accreditation and outcome services for non-accredited organizations. CME Outfitters focuses on delivering education to specialty audiences, with strong expertise in neuroscience, inflammatory, infectious, and autoimmune diseases, and cardiovascular disease. For a complete list of certified activities and more information, visit http://www.cmeoutfitters.com or call 877.CME.PROS (877.263.7767).

“CME Outfitters …
Improving Clinical Behavior … One Change at a Time”

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Anna Larkin
Visit website